Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease

NCT: NCT05536310 · TERMINATED

NCT IDNCT05536310
StatusTERMINATED
Start Date2023-08-01
Completion2024-07-09
SponsorJenaValve Technology, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To collect information about the management of symptomatic severe Aortic Stenosis (AS) and Aortic Regurgitation (AR) using transcatheter aortic valve replacement (TAVI).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑